Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 4Unknown 2Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 4Gastrointestinal 4Thoracic 2Tumor-Agnostic 1Other 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Lung Neoplasms 2Pleural Effusion, Malignant 1

Interventions

Carboplatin 132Cisplatin 129Pemetrexed 114Docetaxel 81Drug Therapy 62Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 36Nivolumab 33Vinorelbine 31Radiosurgery 30sintilimab 29durvalumab 25aumolertinib 25endostar protein 24atezolizumab 22Endostatins 22toripalimab 19Blood Specimen Collection 19tislelizumab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lidocaine × Thoracic × Clear all
NCT05850702 2023-05-09

Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine

RenJi Hospital

Phase 4 Unknown
92 enrolled
Thoracic

Lung Neoplasms

NCT02825095 2016-07-07

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

Rambam Health Care Campus

Phase EARLY_PHASE1 Unknown
120 enrolled
Thoracic

Lung Neoplasms, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡